{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:40:04Z","timestamp":1788471604067,"version":"build-2803163510"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24634-z","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:23:29Z","timestamp":1763555009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cerebrovascular complications in pediatric patients with acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"15","author":[{"given":"Agata","family":"Rocka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Majka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Lipniarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Suchcicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Lejman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Zawitkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"24634_CR1","doi-asserted-by":"crossref","unstructured":"Childhood cancer: Estimating regional and global incidence. Cancer Epidemiology [Internet]. 71:101662. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1877782119301729?via%3Dihub (2021).","DOI":"10.1016\/j.canep.2019.101662"},{"issue":"4","key":"24634_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.pediatrneurol.2015.03.006","volume":"53","author":"B Baytan","year":"2015","unstructured":"Baytan, B., Evim, M. S., G\u00fcler, S., G\u00fcne\u015f, A. M. & Okan, M. Acute central nervous system complications in pediatric acute lymphoblastic leukemia. Pediatr. Neurol. 53(4), 312\u2013318 (2015).","journal-title":"Pediatr. Neurol."},{"key":"24634_CR3","doi-asserted-by":"crossref","unstructured":"Hamoda A, Bedair M, Semary SF, Youssef A, Hafez H. Patterns and outcomes of acute central nervous system complications during treatment of childhood acute lymphoblastic leukemia: a single-center experience. J. Pediatr. Hematol.\/Oncol. [Internet]. 2024 Jan;46(2):72\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38132573\/","DOI":"10.1097\/MPH.0000000000002797"},{"issue":"6","key":"24634_CR4","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3109\/10428191003754608","volume":"51","author":"R Parasole","year":"2010","unstructured":"Parasole, R. et al. Central nervous system complicationsduring treatment of acute lymphoblastic leukemia in a single pediatric institution. Leuk Lymphoma 51(6), 1063\u20131071 (2010).","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"24634_CR5","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3324\/haematol.2021.280016","volume":"107","author":"S Anastasopoulou","year":"2022","unstructured":"Anastasopoulou, S. et al. Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: Phenotypes, risk factors and genotypes. Haematologica 107(10), 2318 (2022).","journal-title":"Haematologica"},{"key":"24634_CR6","unstructured":"Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou TY, Molloy PT. Childhood leukemia: Central nervous system abnormalities during and after treatment. AJNR American journal of neuroradiology [Internet]. 1996 Feb;17(2):295\u2013310. https:\/\/pubmed.ncbi.nlm.nih.gov\/8938302\/"},{"key":"24634_CR7","doi-asserted-by":"crossref","unstructured":"Walker, R.W. Neurologic complications of leukemia. Neurologic clinics [Internet]. 1991 Nov;9(4):989\u201399. https:\/\/pubmed.ncbi.nlm.nih.gov\/1758436\/","DOI":"10.1016\/S0733-8619(18)30261-5"},{"key":"24634_CR8","doi-asserted-by":"crossref","unstructured":"Feinberg, W.M. & Swenson, M.R. Cerebrovascular complications of L-asparaginase therapy. Neurology [Internet]. 1988 Jan;38(1):127\u201333. https:\/\/pubmed.ncbi.nlm.nih.gov\/3275903\/","DOI":"10.1212\/WNL.38.1.127"},{"key":"24634_CR9","doi-asserted-by":"crossref","unstructured":"Biti, G.P., Magrini, S.M., Villari, N., Caramella, D., Guazzelli, G., Rosi, A., et al. Brain damage after treatment for acute lymphoblastic leukemia. A report on 34 patients with special regard to MRI findings. Acta oncologica (Stockholm, Sweden) [Internet]. 1989;28(2):253\u20136. https:\/\/pubmed.ncbi.nlm.nih.gov\/2736115\/","DOI":"10.3109\/02841868909111258"},{"issue":"2","key":"24634_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/1097-0142(197502)35:2<319::AID-CNCR2820350205>3.0.CO;2-3","volume":"35","author":"J Flament-Durand","year":"1975","unstructured":"Flament-Durand, J., Ketelbant-Balasse, P., Maurus, R., Regnier, R. & Spehl, M. Intracerebral calcifications that appear during the course of acute lymphocytic leukemia treated with methotrexate and X-rays. Cancer 35(2), 319\u2013325 (1975).","journal-title":"Cancer"},{"issue":"5","key":"24634_CR11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/RCT.0000000000001481","volume":"47","author":"EJ Snyder","year":"2023","unstructured":"Snyder, E. J., Sarma, A., Poussaint, T. Y., Krishnasarma, R. & Pruthi, S. Complications of cancer therapy in children: A comprehensive review of neuroimaging findings. J. Comput. Assist. Tomogr. 47(5), 820\u2013832 (2023).","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"9","key":"24634_CR12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/children9091337","volume":"9","author":"AS AlGhamdi","year":"2022","unstructured":"AlGhamdi, A. S. Novel ensemble model recommendation approach for the detection of dyslexia. Children 9(9), 1337 (2022).","journal-title":"Children"},{"key":"24634_CR13","doi-asserted-by":"crossref","unstructured":"Ochs JJ, Bowman WP, Pui CH, Abromowitch M, Mason C, Simone JV. Seizures in childhood lymphoblastic leukaemia patients. Lancet (London, England) [Internet]. 1984 Summer;2(8417\u20138418):1422\u20134. https:\/\/pubmed.ncbi.nlm.nih.gov\/6151043","DOI":"10.1016\/S0140-6736(84)91621-0"},{"issue":"10","key":"24634_CR14","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1080\/10428194.2019.1594210","volume":"60","author":"MGZ Ghali","year":"2019","unstructured":"Ghali, M. G. Z., Davanzo, J., Leo, M. & Rizk, E. Posterior reversible encephalopathy syndrome in pediatric patients: Pathophysiology, diagnosis, and management. Leuk. Lymphoma 60(10), 2365\u20132372 (2019).","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"24634_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/ejh.12984","volume":"100","author":"D Zama","year":"2017","unstructured":"Zama, D. et al. A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome. Eur. J. Haematol. 100(1), 75\u201382 (2017).","journal-title":"Eur. J. Haematol."},{"key":"24634_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-39708-5","volume-title":"Childhood acute lymphoblastic leukemia","author":"A Vora","year":"2017","unstructured":"Vora, A. Childhood acute lymphoblastic leukemia (Springer, 2017)."},{"issue":"4","key":"24634_CR17","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/leu.2012.328","volume":"27","author":"J Bond","year":"2012","unstructured":"Bond, J. et al. Stroke-like syndrome caused by intrathecal methotrexate in patients treated during the UKALL 2003 trial. Leukemia 27(4), 954\u2013956 (2012).","journal-title":"Leukemia"},{"issue":"9","key":"24634_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","volume":"32","author":"D Bhojwani","year":"2014","unstructured":"Bhojwani, D. et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 32(9), 949\u2013959 (2014).","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"24634_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/bjh.13162","volume":"168","author":"S Ranta","year":"2014","unstructured":"Ranta, S. et al. Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and Oncology. Br. J. Haematol. 168(4), 547\u2013552 (2014).","journal-title":"Br. J. Haematol."},{"issue":"8","key":"24634_CR20","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3174\/ajnr.A6624","volume":"41","author":"K Ozturk","year":"2020","unstructured":"Ozturk, K., Rykken, J. & McKinney, A. M. Pediatric acute toxic leukoencephalopathy: Prediction of the clinical outcome by FLAIR and DWI for various etiologies. Am. J. Neuroradiol. 41(8), 1517\u20131524 (2020).","journal-title":"Am. J. Neuroradiol."},{"key":"24634_CR21","doi-asserted-by":"crossref","unstructured":"Zadeh, C., AlArab, N., Muwakkit, S., Atweh, L.A., Tamim, H., Makki, M., et al. Stroke in Middle Eastern children with cancer: Prevalence and risk factors. BMC neurology [Internet].22(1):31.: https:\/\/pubmed.ncbi.nlm.nih.gov\/35042459\/ (2022)","DOI":"10.1186\/s12883-022-02556-x"},{"key":"24634_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2019.06.005","volume":"99","author":"U Intusoma","year":"2019","unstructured":"Intusoma, U., Nakorn, C. N. & Chotsampancharoen, T. Intracranial hemorrhage in childhood acute Leukemia: Incidence, characteristics, and contributing factors. Pediatr. Neurol. 99, 23\u201330 (2019).","journal-title":"Pediatr. Neurol."},{"key":"24634_CR23","doi-asserted-by":"crossref","unstructured":"Rahiman, E.A., Rajendran, A., Sankhyan, N., Singh, P., Muralidharan, J., Bansal, D., et al. Acute neurological complications during acute lymphoblastic leukemia therapy: A single-center experience over 10 years. Indian journal of cancer [Internet]. 58(4):545\u201352. https:\/\/pubmed.ncbi.nlm.nih.gov\/34380827\/ (2021).","DOI":"10.4103\/ijc.IJC_422_19"},{"issue":"7","key":"24634_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1586\/14737140.2014.911089","volume":"14","author":"PF Peddi","year":"2014","unstructured":"Peddi, P. F., Peddi, S., Santos, E. S. & Morgensztern, D. Central nervous system toxicities of chemotherapeutic agents. Expert Rev. Anticancer Ther. 14(7), 857\u2013863 (2014).","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"6","key":"24634_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/NRL.0000000000000105","volume":"21","author":"J How","year":"2016","unstructured":"How, J., Blattner, M., Fowler, S., Wang-Gillam, A. & Schindler, S. E. Chemotherapy-associated posterior reversible encephalopathy syndrome. Neurologist 21(6), 112\u2013117 (2016).","journal-title":"Neurologist"},{"key":"24634_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.leukres.2017.12.010","volume":"65","author":"NC Millan","year":"2018","unstructured":"Millan, N. C. et al. Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia. Leuk. Res. 65, 86\u201393 (2018).","journal-title":"Leuk. Res."},{"issue":"1","key":"24634_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ajh.21897","volume":"86","author":"JM Vagace","year":"2010","unstructured":"Vagace, J. M. et al. Methotrexateinduced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis. Am. J. Hematol. 86(1), 98\u2013101 (2010).","journal-title":"Am. J. Hematol."},{"issue":"51","key":"24634_CR28","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/cpt1972135part1694","volume":"13","author":"Boston Collaborative Drug Surveillance Program","year":"1972","unstructured":"Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin. Pharmacol. Therapeut. 13(51), 694\u2013698 (1972).","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"3","key":"24634_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0306-4530(94)90064-7","volume":"19","author":"O Wolkowitz","year":"1994","unstructured":"Wolkowitz, O. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19(3), 233\u2013255 (1994).","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"24634_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/jns.12114","volume":"20","author":"EM Lavoie","year":"2015","unstructured":"Lavoie, E. M. et al. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J. Peripher. Nerv. Syst. 20(1), 37\u201346 (2015).","journal-title":"J. Peripher. Nerv. Syst."},{"key":"24634_CR31","doi-asserted-by":"crossref","unstructured":"Moghrabi, A., Levy, D.E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood [Internet]. [cited 2022 Sep 28];109(3):896\u2013904. https:\/\/ashpublications.org\/blood\/article\/109\/3\/896\/23859\/Results-of-the-Dana-FarberCancer-Institute-ALL (2006)","DOI":"10.1182\/blood-2006-06-027714"},{"issue":"8","key":"24634_CR32","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.ejca.2005.02.013","volume":"41","author":"CT Peng","year":"2005","unstructured":"Peng, C. T. et al. Amino acid concentrations in cerebrospinal fluid in children withacute lymphoblastic leukemia undergoing chemotherapy. Eur. J. Cancer 41(8), 1158\u20131163 (2005).","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"24634_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40263-019-00650-2","volume":"33","author":"SE Gruenbaum","year":"2019","unstructured":"Gruenbaum, S. E. et al. Branched-chain amino acids and seizures: A systematic review of the literature. CNS Drugs 33(8), 755\u2013770 (2019).","journal-title":"CNS Drugs"},{"issue":"6","key":"24634_CR34","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.1987.5.6.927","volume":"5","author":"RH Herzig","year":"1987","unstructured":"Herzig, R. H. et al. Cerebellar toxicity with high-dose cytosine arabinoside. J. Clin. Oncol. 5(6), 927\u2013932 (1987).","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"24634_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/1097-0142(19830201)51:3<426::AID-CNCR2820510312>3.0.CO;2-S","volume":"51","author":"MC Salinsky","year":"1983","unstructured":"Salinsky, M. C., Levine, R. L., Aubuchon, J. P. & Schutta, H. S. Acute cerebellar dysfunction with high-dose ARA-C therapy. Cancer 51(3), 426\u2013429 (1983).","journal-title":"Cancer"},{"issue":"7716","key":"24634_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41586-018-0342-5","volume":"560","author":"H Yao","year":"2018","unstructured":"Yao, H. et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature 560(7716), 55\u201360 (2018).","journal-title":"Nature"},{"issue":"2","key":"24634_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02859383","volume":"69","author":"M Ray","year":"2002","unstructured":"Ray, M., Marwaha, R. K. & Trehan, A. Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia. Ind. J. Pediatr. 69(2), 185\u2013187 (2002).","journal-title":"Ind. J. Pediatr."},{"issue":"5","key":"24634_CR38","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1200\/JCO.1998.16.5.1712","volume":"16","author":"DH Mahoney","year":"1998","unstructured":"Mahoney, D. H. et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy\u2013a Pediatric Oncology Group study. J. Clin. Oncol. 16(5), 1712\u20131722 (1998).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"24634_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.leukres.2005.09.009","volume":"30","author":"B Kuskonmaz","year":"2006","unstructured":"Kuskonmaz, B. et al. The neurologic complications in pediatric acute lymphoblastic leukemia patients excluding leukemic infiltration. Leuk. Res. 30(5), 537\u2013541 (2006).","journal-title":"Leuk. Res."},{"key":"24634_CR40","unstructured":"Ayta\u00e7, S., Yetgin, S. & Tavil, B. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia. The Turkish J. Pediatr. 48(1):1\u20137. https:\/\/pubmed.ncbi.nlm.nih.gov\/16562778\/ (2006)."},{"issue":"5","key":"24634_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/1096-911X(20001101)35:5<449::AID-MPO2>3.0.CO;2-X","volume":"35","author":"LL Nigro","year":"2000","unstructured":"Nigro, L. L., Cataldo, A. D. & Schiliro, G. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols. Med. Pediatr. Oncol. 35(5), 449\u2013455 (2000).","journal-title":"Med. Pediatr. Oncol."},{"issue":"4","key":"24634_CR42","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4103\/0973-1482.168993","volume":"11","author":"N Kamath","year":"2015","unstructured":"Kamath, N., Sankhe, S. & Sahu, A. A rare case of chemotherapy induced reversible cerebral vasoconstriction syndrome in a patient of acute lymphocytic leukemia. J Canc Res Therapeut 11(4), 1012\u20131012e (2015).","journal-title":"J Canc Res Therapeut"},{"issue":"1","key":"24634_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1941874417698324","volume":"8","author":"JD Avila","year":"2017","unstructured":"Avila, J. D. Methotrexate-induced neurotoxicity: An uncommon stroke mimic. The Neurohospitalist 8(1), 46\u201347 (2017).","journal-title":"The Neurohospitalist"},{"issue":"4","key":"24634_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MPH.0000000000001408","volume":"41","author":"HA Hafez","year":"2019","unstructured":"Hafez, H. A., Soliaman, R. M., Bilal, D., Hashem, M. & Shalaby, L. M. Early deaths in pediatric acute leukemia: A major challenge in developing countries. J. Pediatr. Hematol. Oncol. 41(4), 261\u2013266 (2019).","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"8","key":"24634_CR45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1528-1157.1995.tb01622.x","volume":"36","author":"J Maytal","year":"1995","unstructured":"Maytal, J. et al. Prognosis and treatment of eizures in children with acute lymphoblastic leukemia. Epilepsia 36(8), 831\u2013836 (1995).","journal-title":"Epilepsia"},{"issue":"3","key":"24634_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1212\/WNL.56.3.388","volume":"56","author":"RK Shin","year":"2001","unstructured":"Shin, R. K., Stern, J. W., Janss, A. J., Hunter, J. A. & Liu, G. R. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 56(3), 388\u2013391 (2001).","journal-title":"Neurology"},{"issue":"7201","key":"24634_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/bmj.319.7201.54","volume":"319","author":"G Pratt","year":"1999","unstructured":"Pratt, G. et al. Cyclosporin neurotoxicity after chemotherapy. BMJ 319(7201), 54\u201364 (1999).","journal-title":"BMJ"},{"issue":"1","key":"24634_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1046\/j.1365-2141.2003.04447.x","volume":"122","author":"R Wong","year":"2003","unstructured":"Wong, R. et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br. J. Haematol. 122(1), 128\u2013134 (2003).","journal-title":"Br. J. Haematol."},{"issue":"4","key":"24634_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jemermed.2016.11.016","volume":"52","author":"P Rogers","year":"2017","unstructured":"Rogers, P., Pan, W. J., Drachtman, R. A. & Haines, C. A stroke Mimic: Methotrexate-induced neurotoxicity in the emergency department. J. Emerg. Med. 52(4), 559\u2013561 (2017).","journal-title":"J. Emerg. Med."},{"issue":"3","key":"24634_CR50","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1157\/13116711","volume":"68","author":"J Hualde Olascoaga","year":"2008","unstructured":"Hualde Olascoaga, J. et al. Leucoencefalopat\u00eda posterior reversible: Descripci\u00f3n de dos casos asociados a vincristina. An Pediatr (Barc) 68(3), 282\u2013285 (2008).","journal-title":"An Pediatr (Barc)"},{"issue":"2","key":"24634_CR51","first-page":"e2799","volume":"67","author":"J Banerjee","year":"2019","unstructured":"Banerjee, J. et al. The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia. Pediatr. Blood Canc. 67(2), e2799 (2019).","journal-title":"Pediatr. Blood Canc."},{"issue":"3","key":"24634_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","volume":"14","author":"A Vora","year":"2013","unstructured":"Vora, A. et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): A randomised controlled trial. Lancet Oncol. 14(3), 199\u2013209 (2013).","journal-title":"Lancet Oncol."},{"issue":"6","key":"24634_CR53","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/S1470-2045(16)30035-3","volume":"17","author":"K Schmiegelow","year":"2016","unstructured":"Schmiegelow, K. et al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: A Delphi consensus. Lancet Oncol. 17(6), e231\u2013e239 (2016).","journal-title":"Lancet Oncol."},{"issue":"2","key":"24634_CR54","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2169\/internalmedicine.7520-21","volume":"61","author":"Y Ando","year":"2022","unstructured":"Ando, Y., Ono, Y., Sano, A., Fujita, N. & Ono, S. Posterior reversible encephalopathy syndrome: A review of the literature. Intern. Med. 61(2), 135\u2013141 (2022).","journal-title":"Intern. Med."},{"key":"24634_CR55","doi-asserted-by":"publisher","first-page":"824268","DOI":"10.3389\/fneur.2022.824268","volume":"13","author":"R Li","year":"2022","unstructured":"Li, R. et al. Clinical analysis of childhood acute lymphoblastic leukemia with epilepsy seizures. Front. Neurol. 13, 824268 (2022).","journal-title":"Front. Neurol."},{"issue":"4","key":"24634_CR56","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1055\/s-2008-1046626","volume":"206","author":"G Fleischhack","year":"1994","unstructured":"Fleischhack, G. et al. Bildgebende Verfahren in der Diagnostik zerebrovaskul\u00e4rer Komplikationen unter L-Asparaginase-Therapie. Klin. Padiatr. 206(4), 334\u2013341 (1994).","journal-title":"Klin. Padiatr."},{"key":"24634_CR57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0268-9499(94)90248-8","volume":"8","author":"U Nowak-G\u00f6ttl","year":"1994","unstructured":"Nowak-G\u00f6ttl, U. et al. Enhanced thrombin generation, P-von willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginasetreated children. Fibrinol. Proteol. 8, 63\u201365 (1994).","journal-title":"Fibrinol. Proteol."},{"issue":"3","key":"24634_CR58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002770050324","volume":"75","author":"A Corso","year":"1997","unstructured":"Corso, A., Castagnola, C. & Bernasconi, C. Thrombotic events are not exclusive to the remission induction period in patients with acute lymphoblastic leukemia: A report of two cases of cerebral sinus thrombosis. Ann. Hematol. 75(3), 117\u2013119 (1997).","journal-title":"Ann. Hematol."},{"issue":"1","key":"24634_CR59","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1046\/j.1365-2141.2003.04447.x","volume":"122","author":"R Wong","year":"2003","unstructured":"Wong, R. et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br. J. Haemat. 122(1), 128\u2013134 (2003).","journal-title":"Br. J. Haemat."},{"issue":"2","key":"24634_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0887-8994(00)00242-3","volume":"24","author":"R S\u00e1nchez-Carpintero","year":"2001","unstructured":"S\u00e1nchez-Carpintero, R., Narbona, J., L\u00f3pez de Mesa, R., Arbizu, J. & Sierrases\u00famaga, L. Transient posterior encephalopathy induced by chemotherapy in children. Pediatr. Neurol. 24(2), 145\u2013148 (2001).","journal-title":"Pediatr. Neurol."},{"issue":"17","key":"24634_CR61","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1200\/JCO.19.03024","volume":"38","author":"S Gupta","year":"2020","unstructured":"Gupta, S. et al. Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: A report from the children\u2019s oncology group. J. Clin. Oncol. 38(17), 1897\u20131905 (2020).","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"24634_CR62","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0025-7753(02)73580-X","volume":"119","author":"M Oca\u00f1a Rico","year":"2002","unstructured":"Oca\u00f1a Rico, M., Javier Manch\u00f3n, G., Coroleu Lletget, W. & Capellades, F. J. Encefalopat\u00eda posterior reversible durante el tratamiento de inducci\u00f3n de la leucemia linfobl\u00e1stica aguda. Med. Clin. 119(20), 795\u2013796 (2002).","journal-title":"Med. Clin."},{"issue":"1","key":"24634_CR63","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41390-024-03351-9","volume":"97","author":"R Bansal","year":"2025","unstructured":"Bansal, R. et al. Progression of brain injuries associated with methotrexate chemotherapy in childhood acute lymphoblastic leukemia. Pediatr. Res. 97(1), 348\u2013359 (2025).","journal-title":"Pediatr. Res."},{"issue":"1","key":"24634_CR64","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/0971-5851.133727","volume":"35","author":"MA Appachu","year":"2014","unstructured":"Appachu, M. A., Purohit, S., Lakshmaiah, K. C., Aruna, B. K. & Appaji, L. Posterior reversible encephalopathy syndrome in pediatric acute leukemia: Case series and literature review. Indian J. Med. Paediatr. Oncol. 35(1), 79\u201382 (2014).","journal-title":"Indian J. Med. Paediatr. Oncol."},{"issue":"4","key":"24634_CR65","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00381-017-3664-y","volume":"34","author":"K Musio\u0142","year":"2017","unstructured":"Musio\u0142, K. et al. PRES in the course of hemato-oncological treatment in children. Child\u2019s Nerv. Syst. 34(4), 691 (2017).","journal-title":"Child\u2019s Nerv. Syst."},{"issue":"4","key":"24634_CR66","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jemermed.2016.11.016","volume":"52","author":"P Rogers","year":"2017","unstructured":"Rogers, P., Pan, W. J., Drachtman, R. A. & Haines, C. A stroke mimic: Methotrexate-induced neurotoxicity in t6he emergency department. J. Emerg. Med. 52(4), 559\u201361.43 (2017).","journal-title":"J. Emerg. Med."},{"issue":"6","key":"24634_CR67","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s12185-018-2525-0","volume":"108","author":"K Watanabe","year":"2018","unstructured":"Watanabe, K. et al. Characteristics of methotrexate-induced stroke-like neurotoxicity. Int. J. Hematol. 108(6), 630\u2013636 (2018).","journal-title":"Int. J. Hematol."},{"issue":"3","key":"24634_CR68","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0887-8994(02)00508-8","volume":"28","author":"NL Antunes","year":"2003","unstructured":"Antunes, N. L. Seizures in children with systemic cancer. Pediatr. Neurol. 28(3), 190\u2013193 (2003).","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"24634_CR69","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","volume":"84","author":"ML Madsen","year":"2019","unstructured":"Madsen, M. L. et al. Aspects of vincristine-induced neuropathy in hematologic malignancies: A systematic review. Canc. Chemother. Pharmacol. 84(3), 471\u2013485 (2019).","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"4","key":"24634_CR70","first-page":"144","volume":"18","author":"K Faber","year":"2014","unstructured":"Faber, K. et al. Neurological toxicities among children patients during treatment for acute lymphoblastic leukemia and occurrence of neuropsychological late effects after the treatment. Psychoonkologia 18(4), 144\u2013152 (2014).","journal-title":"Psychoonkologia"},{"issue":"3","key":"24634_CR71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5603\/AHP.a2023.0033","volume":"54","author":"J Krasinka","year":"2023","unstructured":"Krasinka, J., Trelinska, J., Walenciak, J., Dachowska-Ka\u0142wak, I. & M\u0142ynarski, W. Central neurotoxicity \u00b4 as a complication in course of treatment of acute lymphoblastic leukemia in children: A single center experience. Acta Haematol. Pol. 54(3), 145\u2013153 (2023).","journal-title":"Acta Haematol. Pol."},{"issue":"3","key":"24634_CR72","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11060-012-0852-1","volume":"108","author":"T Mizutani","year":"2012","unstructured":"Mizutani, T. et al. Radiation-induced vascular injury and its management in cancer patients. J. Neurooncol. 108(3), 423\u2013432 (2012).","journal-title":"J. Neurooncol."},{"issue":"4","key":"24634_CR73","first-page":"545","volume":"58","author":"EA Rahiman","year":"2021","unstructured":"Rahiman, E. A. et al. Acute neurological complications during acute lymphoblastic leukemia therapy: A single-center experience over 10 years. Ind. J. Canc. 58(4), 545\u2013552 (2021).","journal-title":"Ind. J. Canc."},{"issue":"6","key":"24634_CR74","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/00043426-200306000-00011","volume":"25","author":"M Kieslich","year":"2003","unstructured":"Kieslich, M. et al. Cerebrovascular complications of l-Asparaginase in the therapy of acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol. 25(6), 484\u2013487 (2003).","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"2","key":"24634_CR75","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00234-016-1777-8","volume":"59","author":"O Zajac-Spycha\u0142a","year":"2017","unstructured":"Zajac-Spycha\u0142a, O. et al. Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy. Neuroradiology 59(2), 147\u2013156 (2017).","journal-title":"Neuroradiology"},{"issue":"1","key":"24634_CR76","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13014-015-0562-x","volume":"10","author":"PF Tsai","year":"2015","unstructured":"Tsai, P. F. et al. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: A prospective study. Radiat. Oncol. 10(1), 253 (2015).","journal-title":"Radiat. Oncol."},{"issue":"2","key":"24634_CR77","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pbc.24263","volume":"60","author":"M Monje","year":"2012","unstructured":"Monje, M. et al. Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia. Pediatr. Blood Canc. 60(2), 293\u2013300 (2012).","journal-title":"Pediatr. Blood Canc."},{"issue":"2","key":"24634_CR78","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.bbr.2007.08.004","volume":"186","author":"R Seigers","year":"2008","unstructured":"Seigers, R. et al. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav. Brain Res. 186(2), 168\u2013175 (2008).","journal-title":"Behav. Brain Res."},{"issue":"1","key":"24634_CR79","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3324\/haematol.2015.131680","volume":"101","author":"T Oskarsson","year":"2015","unstructured":"Oskarsson, T. et al. Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: Prognostic factors, treatment and outcome. Haematologica 101(1), 68\u201376 (2015).","journal-title":"Haematologica"},{"issue":"10","key":"24634_CR80","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.3390\/ijms23105515","volume":"23","author":"P Sliwa-Tytko","year":"2022","unstructured":"Sliwa-Tytko, P., Kaczmarska, A., Lejman, M. & Zawitkowska, J. Neurotoxicity associated with treatment of Acute \u00b4 lymphoblastic leukemia chemotherapy and immunotherapy. Int. J. Mol. Sci. 23(10), 5515 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"24634_CR81","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3324\/haematol.2020.268565","volume":"107","author":"MK Mateos","year":"2022","unstructured":"Mateos, M. K. et al. Methotrexate-related central neurotoxicity: Clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. Haematologica [Internet]. 107(3), 635\u2013643 (2022).","journal-title":"Haematologica [Internet]."},{"key":"24634_CR82","doi-asserted-by":"crossref","unstructured":"Wardlaw, J. M., Keir, S.L., & Dennis, M.S. The impact of delays in computed tomography of the brain on the accuracy of diagnosis and subsequent management in patients with minor stroke. J. Neurol., Neurosurg. Psychiatry [Internet]. 74(1):77\u201381. https:\/\/jnnp.bmj.com\/content\/74\/1\/77 (2003).","DOI":"10.1136\/jnnp.74.1.77"},{"key":"24634_CR83","doi-asserted-by":"crossref","unstructured":"Siddiqui, F.M., Bekker, S.V. & Qureshi, A.I. Neuroimaging of hemorrhage and vascular defects. Neurotherapeut: J. Am. Soci. Exper. NeuroTherapeut [Internet]. 8(1):28\u201338. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3075731\/ (2011).","DOI":"10.1007\/s13311-010-0009-x"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24634-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24634-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T13:04:00Z","timestamp":1763557440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24634-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24634"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24634-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration 105 of Helsinki, and approved by the Bioethics Committee of the Medical University of Lublin KE-0254\/208\/10\/2022.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}}],"article-number":"40825"}}